Various studies have supported that mTORC1 inhibition can increase insulin sensitivity and glucose metabolism in animal models of T2D.42,43 These results provide strong confirmation of the involvement of these pathways in the pathogenesis of T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.